Decreased corticosensitivity in quiescent Crohn's disease: An ex vivo study using whole blood cell cultures

Digestive Diseases and Sciences

Volumn 44, Issue 6, 1999, Pages 1208-1215

  Franchimont, Denis ^a   Louis, Edouard ^a   Dupont, Pierre ^a   Vrindts Gevaert, Yvonne ^a   Dewe, Walthere ^a   Chrousos, George ^a   Geenen, Vincent ^a   Belaiche, Jacques ^a,b  

^a Laboratory of Immunology   (United States)

^b CHU SART TILMAN   (Belgium)

Author keywords

Corticosensitivity; Crohn's disease; Cytokines; Glucocorticoids

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; INFLAMMATION; MALE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; BLOOD CELLS; CELLS, CULTURED; CROHN DISEASE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOASSAY; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; SALMONELLA ENTERITIDIS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033031405     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026644711530     Document Type: Article

References (35)

1. 1. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 20:1351-1362, 1995
2. 2. Wilder RL: Neuroendocrine-immune system interactions and autoimmunity. Ann Rev Immunol 13:307-338, 1995
3. 3. Besedovsky HO, Del Rcy A: Immune-neuro-endocrine interactions: Facts and hypotheses. Endoer Rev 17:64-102, 1996
4. 4. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 86:2374-2378, 1989
5. 5. Sternberg EM, Scott Young W, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL; A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 86:4771-4775, 1989
6. 6. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE: Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 119:1198-1208, 1993
7. 7. Landi B, N'Guyen Anh T, Cortot A, Soule JC, Rene E, Gendre JP, Boiries P, See A, Metman EH, Florent C, Lerebours E, Mary JY, Modigliani R, GETAID: Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial. Gastroenterology 102:1647-1653, 1992
8. 8. Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soulé JC, Gendre JP, Galmiche JP, Danne O, Guillaume C, Lamouliatte H, Belaiche J, Mary JY, GETAID: Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance. Gastroenterology 110:688-693, 1996
9. 9. Munkholm P, Langholz E, Davidsen M, Binder V: Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 35:360-362, 1994
10. 10. Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Rene E, GETAID: Clinical, biological and endoscopic picture of attacks of Crohn's disease. Gastroenterology 98:811-818, 1990
11. 11. Chrousos GP, Castro M, Leung DM, Webster E, Kino T, Bamberger C, Elliot S, Stratakis C, Karl M: Molecular mechanisms of glucocorticoid resistance and hypersensitivity. Am J Crit Care Med 154:S39-S44, 1996
12. 12. Bamberger CM, Schulte HM, Chrousos GP: Molecular Determinants of glucocorticoid receptor. Function and tissue sensitivity to glucocorticoids. Endoer Rev 17:245-261, 1996
13. 13. Chrousos GP, Detera S, Karl M: Syndroms of glucocorticoid resistance. Ann Intern Med 19:113-1124, 1993
14. 14. Lamberts SWJ, Poldermans D, Zweens M, de Jong FH: Familial cortisol resistance: Differential diagnostic and therapeutic aspects. J Clin Endocrinol Metab 63:1328-1333, 1986
15. 15. Sher ER, Leung DYM, Surs W, Kam JC, Zieg G, Kamada AK, Harbeck R, Szefler SJ: Steroid resistant asthma: Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93:33-39, 1994
16. 16. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C: Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 35:740-744, 1994
17. 17. Schlaghecke R, Beuscher D, Kornely E, Specker C: Effects of glucocorticoids in rheumatoid arthritis. Arthritis Rheum 37:1127-1131, 1994
18. 18. Franchimom D, Louis E, Martens H, De Groote D, Belaiche J, Geenen V: Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept 73:59-65, 1998
19. 19. Franchimont D, Louis E, Croes F, Belaiche J: Clinical pattern of corticosteroid-dependent Crohn's disease. Eur J Gastroenterol Hepatol 10:821-825, 1998
20. 20. De Groote D, Zangerle PF, Gevaert Y, Fassote MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P: Direct stimulation of cytokines in whole blood. Comparison with isolated PBMC stimulation. Cytokine 4:239-248, 1992
21. 21. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ, Kay AB: Glucocorticoid resistance in chronic asthma. Am Rev Respir Dis 144:1016-1025, 1991
22. 22. Alvarez J, Surs W, Leung DYM, Iklé D, Gelfand EW, Szefler SJ: Steroid-resistant asthma: Immunologic and pharmacologic features. J Allergy Clin Immunol 89:714-721, 1992
23. 23. Mazlam MZ, Hodgson HJF: Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 33:773-778, 1992
24. 24. Costas M, Trapp Thorsen, Pereda MP, Sauer J, Rupprecht R, Nahmod VE, Reul J MHM, Holsboer F, Artz E: Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. J Clin Invest 98:1409-1416, 1996
25. 25. Rakasz E, Gal A, Biro J, Balas G, Falus A: Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines IL-1β, IL-6, and TNF-α. Scand J Immunol 37:684-689, 1993
26. 26. Salkowski CA, Vogel SN: IFNγ mediates increased glucocorticoid receptor expression in murine macrophages. J Immunol 148:2770-2777, 1992
27. 27. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY: Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 7:3460-3466, 1993
28. 28. Spahn DS, Szefler J, Surs W, Doherty DE, Leung DY: A novel action of interleukin-13; induction of diminished monocyte glucocorticoid receptor binding affinity. J Immunol 157:2654-2659, 1996
29. 29. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NFκB and the glucocorticoid receptor. Froc Natl Acad Sci USA 91:752-756, 1994
30. 30. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M: 1995 Immunosuppression by glucocorticoids: Inhibition of NF-kappaB activity through induction of I kappa B synthesis. Science 270:283-286, 1995
31. 31. Barnes PJ, Karin M: Nuclear Factor-kB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
32. 32. Van der Burg B, Liden J, Okret S, Delaunay F, Wissink S, Van der Saag PT, Gustafsson JA: Nuclear factor-kB repression in anti-inflammation and immunosuppression by glucocorticoids. Trends Endocrinol Metab 8:152-157, 1997
33. 33. Pearson DC, May GR, Fick GH, Sutherland LR: Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 122:132-142, 1995
34. 34. Chikanza IC, Petrou P, Kingsley G, Chrousos GP, Panayi GS: Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 35:1281-1288, 1992
35. 35. Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL: Circadian relationships between interleukin 6 and hypothalamic-pituutary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82:1279-1283, 1997